Amundi’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.5K Buy
+19,130
New +$44.9K ﹤0.01% 1980
2022
Q3
Sell
-185,318
Closed -$1.14M 1860
2022
Q2
$1.14M Buy
185,318
+49,513
+36% +$551K ﹤0.01% 1147
2022
Q1
$2.58M Buy
135,805
+99,168
+271% +$2.27M ﹤0.01% 1084
2021
Q4
$997K Buy
36,637
+14,300
+64% +$575K ﹤0.01% 1296
2021
Q3
$916K Buy
+22,337
New +$810K ﹤0.01% 1307

Other funds holding GDRX

Amundi's GDRX Position: Q1 2026 in Review

Amundi opened a new position in GoodRx Holdings (GDRX) in Q1 2026: 19,130 shares worth $37.5K. The stake represents ﹤0.01% of the portfolio and ranks #1980 among its holdings. This is a return to the name: Amundi previously reported a position in GDRX as recently as Q2 2022.

Amundi first reported a position in GDRX in Q3 2021 and has held it in 5 quarters since. The position peaked at $2.58M in Q1 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Amundi held 19,130 shares of GoodRx Holdings worth $37.5K as of Q1 2026.
  • GoodRx Holdings was a new Amundi position in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1980 holding.
  • Amundi first reported a position in GoodRx Holdings in Q3 2021 and has held it in 5 quarters since.
  • Amundi's GoodRx Holdings position peaked at $2.58M in Q1 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.